SBC Medical Group Expands Global Footprint Through Strategic OrangeTwist Partnership

SBC Medical Group Holdings Inc. (NASDAQ: SBC) has completed a strategic investment in OrangeTwist, a U.S.-based medspa chain, marking the Japanese company's official foray into the American market. This partnership enables SBC to leverage OrangeTwist's existing network of 24 locations across six states while bringing its own operational expertise to enhance service offerings. The collaboration comes as the medical aesthetics industry is forecast to grow from $34 billion to $48 billion by 2030, driven by increasing demand for non-surgical treatments with minimal risk and recovery time.

The aging population in the United States represents a significant driver for non-invasive aesthetic treatments, creating opportunities for companies like SBC and OrangeTwist to address what industry experts call "white space" markets. These are cities with high demand for services but few competitors providing them. By combining resources, the two companies plan to enter these underserved markets and establish first-mover advantages before rivals can respond. Stephen Rodgers, global head of planning and strategy at SBC Medical, emphasized the company's approach to global expansion, stating they seek local partnerships rather than replicating their Japanese model exactly.

Beyond the immediate medical aesthetics market, SBC is positioned to capitalize on the broader longevity industry, which is shifting focus from merely extending lifespan to enhancing "healthspan" through personalized, preventative solutions. According to Gabelli Research, the global anti-aging market, valued at approximately $85 billion in 2025, is expected to surpass $120 billion by 2030, growing at a compound annual growth rate of 7% from 2025-2030. North America accounts for approximately 30% of this market, while Asia also shows robust growth due to beauty-conscious consumers and an aging population.

SBC's expansion strategy extends beyond the United States, with the company actively growing its presence in Japan and Southeast Asia. The company applies its proven business model to help Asian clinics with comprehensive management services, including staff training, medical equipment procurement, and operational optimization. This standardized approach ensures patients receive consistent, high-quality services at predictable price points across different markets. The company's global strategy rests on three core tenets: partnering with high-performing regional operators, deploying SBC's expertise to drive efficiencies, and securing first-mover advantages through innovation.

The partnership with OrangeTwist represents more than just a market entry strategy for SBC Medical Group. It reflects a broader vision to create a global network of aesthetic beauty services through replicable partnership models. By sharing successful approaches and expertise with local providers, SBC aims to establish a single, trusted brand that delivers consistent quality across international markets. This expansion comes as non-invasive cosmetic treatments gain popularity worldwide, particularly in markets where consumers prefer natural-looking results with minimal recovery time.